Newswise — Erlanger Health System and Vanderbilt University Medical Center, on behalf of Vanderbilt-Ingram Cancer Center (VICC), have entered into an agreement to design a long-term collaboration in cancer care, including VICC hematology-oncology services at Erlanger's two clinic and infusion locations.

The agreement targets an effective date of October 1, 2020 for final design of the collaboration and establishing VICC as Erlanger’s exclusive contracted provider of inpatient and outpatient hematology-oncology services and medical directorship for the program. The agreement does not affect Erlanger’s relationship with its medical staff, nor does it prevent other hematologist-oncologists from providing care in Erlanger’s hospitals.

“This collaborative effort offers a unique and important opportunity for Erlanger to not only access the most clinical trials for adults in cancer care, but also to provide the most comprehensive cancer treatment program in this region,” said Tanner Goodrich, Erlanger Vice-President of Operations. “By teaming with Vanderbilt, we will be able to continue to expand our cutting-edge cancer care services to the many communities we serve.”      

Over the next year, VICC and Erlanger will pursue plans to expand the hematology-oncology collaboration and grow the scope of services consistent with Erlanger’s vision for cancer care and VICC’s National Cancer Institute-Designated cancer center capabilities.  

“Our mission at Vanderbilt-Ingram is to share our clinical expertise and discoveries for the benefit of cancer patients everywhere, and this collaboration with Erlanger Health System is an example of our commitment to the care of cancer patients throughout the region,” said Jennifer Pietenpol, Ph.D., Byrd Jr. Professor of Oncology, director of Vanderbilt-Ingram and Executive Vice President for Research at Vanderbilt University Medical Center.

About Erlanger Health System:  

The Chattanooga-based Erlanger Health System is the tri-state region’s only Level 1 Trauma Center, with seven hospitals, a fleet of six LIFE FORCE air ambulances, and home to Children’s Hospital at Erlanger, the region’s only Level IV Neonatal Intensive Care Unit and pediatric trauma team.  Erlanger offers centers of excellence in cancer care, neurosciences, cardiology, orthopedics, women and children’s services, trauma and transplant services. 

About Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram Cancer Center provides compassionate care, evidence-based prevention, pioneering research, community engagement and survivorship support. Designated a Comprehensive Cancer Center by the National Cancer Institute and a member of the National Comprehensive Cancer Network, Vanderbilt-Ingram is at the forefront of discovery. Vanderbilt-Ingram’s team of scientists and clinicians are defining personalized care with immunotherapies, targeted treatments, precision radiation-oncology, innovative surgeries and novel imaging technologies.